Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy - PubMed (original) (raw)
Case Reports
. 1989 Jan 19;320(3):138-42.
doi: 10.1056/NEJM198901193200302.
Affiliations
- PMID: 2643040
- DOI: 10.1056/NEJM198901193200302
Case Reports
Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy
K Arahata et al. N Engl J Med. 1989.
Abstract
A deficiency of the protein dystrophin is known to be the cause of Duchenne's muscular dystrophy. To examine the expression of dystrophin in symptomatic female carriers of this X-linked recessive disorder, we performed immunohistochemical studies on muscle-biopsy specimens from three such carriers, using an antiserum raised against a synthetic peptide fragment of dystrophin. In all three carriers, most individual muscle fibers reacted either strongly or not at all to the antiserum for dystrophin; only 2 to 8 percent of fibers showed partial immunostaining. This mosaic staining pattern was present on both cross-sectional and longitudinal muscle specimens. Although the mosaic pattern was seen in all fiber types, more than 80 percent of type 2B and 2C fibers from two of the carriers did not react with the antiserum. Similar studies in nine normal subjects showed consistently strong staining of all muscle fibers. No muscle fibers from 31 patients with Duchenne's muscular dystrophy reacted with the antiserum. We conclude that symptomatic carriers of Duchenne's muscular dystrophy can be identified by a distinct mosaic pattern in the immunohistochemical staining of the surface membrane of skeletal-muscle specimens. This finding may have practical implications for genetic counseling, although it remains to be shown whether the same staining pattern will be found in muscle specimens from asymptomatic carriers of Duchenne's muscular dystrophy.
Comment in
- Dystrophin and Duchenne's muscular dystrophy.
Hurko O, Johns DR. Hurko O, et al. N Engl J Med. 1989 Aug 10;321(6):398-9. doi: 10.1056/NEJM198908103210616. N Engl J Med. 1989. PMID: 2664525 No abstract available.
Similar articles
- Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, et al. Mendell JR, et al. N Engl J Med. 1995 Sep 28;333(13):832-8. doi: 10.1056/NEJM199509283331303. N Engl J Med. 1995. PMID: 7651473 Clinical Trial. - Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy.
Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L, et al. Hoffman EP, et al. N Engl J Med. 1988 May 26;318(21):1363-8. doi: 10.1056/NEJM198805263182104. N Engl J Med. 1988. PMID: 3285207 - Mosaic expression of dystrophin in carriers of canine X-linked muscular dystrophy.
Cooper BJ, Gallagher EA, Smith CA, Valentine BA, Winand NJ. Cooper BJ, et al. Lab Invest. 1990 Feb;62(2):171-8. Lab Invest. 1990. PMID: 2406503 - [Present-day clinico-genetic framework of Duchenne's muscular dystrophy].
Meola G. Meola G. Riv Neurol. 1989 Jan-Feb;59(1):8-14. Riv Neurol. 1989. PMID: 2669113 Review. Italian. - [Molecular genetics of Duchenne's disease].
Bolhuis PA. Bolhuis PA. Ned Tijdschr Geneeskd. 1989 Jul 8;133(27):1347-8. Ned Tijdschr Geneeskd. 1989. PMID: 2571948 Review. Dutch. No abstract available.
Cited by
- A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.
Vainzof M, Passos-Bueno MR, Pavanello RC, Schreiber R, Zatz M. Vainzof M, et al. J Med Genet. 1992 Jul;29(7):476-9. J Med Genet. 1992. PMID: 1640426 Free PMC article. - Parent Project Muscular Dystrophy Females with Dystrophinopathy Conference, Orlando, Florida June 26 - June 27, 2019.
Apkon S, Kinnett K, Cripe L, Duan D, Jackson JL, Kornegay JN, Mah ML, Nelson SF, Rao V, Scavina M, Wong BL, Flanigan KM. Apkon S, et al. J Neuromuscul Dis. 2021;8(2):315-322. doi: 10.3233/JND-200555. J Neuromuscul Dis. 2021. PMID: 33361607 Free PMC article. No abstract available. - Immunohistochemical studies show truncated dystrophins in the myotubes of three fetuses at risk for Duchenne muscular dystrophy.
Ginjaar IB, Bakker E, van Paassen MM, den Dunnen JT, Wessels A, Zubrzycka-Gaarn EE, Moorman AF, van Ommen GJ. Ginjaar IB, et al. J Med Genet. 1991 Aug;28(8):505-10. doi: 10.1136/jmg.28.8.505. J Med Genet. 1991. PMID: 1920366 Free PMC article. - Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle.
Morin A, Stantzou A, Petrova ON, Hildyard J, Tensorer T, Matouk M, Petkova MV, Richard I, Manoliu T, Goyenvalle A, Falcone S, Schuelke M, Laplace-Builhé C, Piercy RJ, Garcia L, Amthor H. Morin A, et al. Proc Natl Acad Sci U S A. 2023 Jan 10;120(2):e2206324120. doi: 10.1073/pnas.2206324120. Epub 2023 Jan 3. Proc Natl Acad Sci U S A. 2023. PMID: 36595689 Free PMC article. - Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.
Arahata K, Hoffman EP, Kunkel LM, Ishiura S, Tsukahara T, Ishihara T, Sunohara N, Nonaka I, Ozawa E, Sugita H. Arahata K, et al. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7154-8. doi: 10.1073/pnas.86.18.7154. Proc Natl Acad Sci U S A. 1989. PMID: 2674948 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical